Besides, vorinostat and bortezomib have been reported to significantly inhibit WT1 gene expression in MO7-e and P39 cell lines, which are in vitro models for leukemia and MDS, respectively (Galimberti et al., 2008). This evidence concerns the gene WT1 and leukemia.